Swiss National Bank Kezar Life Sciences, Inc. Transaction History

Swiss National Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$3.13 - $7.31 $41,316 - $96,492	-13,200 Reduced 10.65%	110,700 $346,000
Q4 2022 Feb 08, 2023	BUY	$6.39 - $8.8 $105,435 - $145,200	16,500 Added 15.36%	123,900 $872,000
Q3 2022 Nov 09, 2022	BUY	$7.99 - $10.75 $57,528 - $77,400	7,200 Added 7.19%	107,400 $925,000
Q2 2022 Aug 09, 2022	BUY	$4.58 - $17.13 $458,916 - $1.72 Million	100,200 New	100,200 $829,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.